Next Article in Journal
Correction: Kargul et al. Beyond Diameter: Enhancing Abdominal Aortic Aneurysm Surveillance with Volumetric Assessments After Endovascular Aneurysm Repair (EVAR). J. Clin. Med. 2023, 12, 6733
Previous Article in Journal
Relationship of Vitamin D, Spondyloarthritis Activity and Left Ventricular Systolic and Diastolic Function
Previous Article in Special Issue
Managing Respiratory Failure in Late Pregnancy
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Liberation from Mechanical Ventilation in Acute Hypoxemic Respiratory Failure or Adult Respiratory Distress Syndrome: A Review

by
Karen E. A. Burns
1,2,*,
Karen J. Bosma
3,4,
Bruno L. Ferreyro
1,5,
Dipayan Chaudhuri
6,7,
Andrew J. E. Seely
8,9 and
Daniel R. Ouellette
10
1
Department of Medicine, Interdepartmental Division of Critical Care, University of Toronto, Toronto, ON M5G 1V7, Canada
2
Department of Medicine, Division of Critical Care, Unity Health Toronto—St. Michael’s Hospital, Toronto, ON M5B 1W8, Canada
3
Faculty of Medicine, The University of Western Ontario, London, ON N6A 3K7, Canada
4
Division of Critical Care, London Health Sciences Centre, London, ON N6A 5A5, Canada
5
Department of Medicine, Sinai Health System, University of Toronto, Toronto, ON M5G 1V7, Canada
6
Department of Critical Care, Division of Critical Care Medicine, Markham-Stoufville Hospital, Markham, ON L3P 7P3, Canada
7
Department of Medicine, Division of Critical Care, McMaster University, Hamilton, ON L8S 4L8, Canada
8
Acute Care Research, Ottawa Hospital Research Institute, The University of Ottawa, Ottawa, ON K1N 6N5, Canada
9
Department of Critical Care, Ottawa Hospital—General Campus, Ottawa, ON K1H 8L6, Canada
10
Division of Pulmonary and Critical Care Medicine, Henry Ford Health System, Detroit, MI 48202, USA
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2026, 15(15), 6019; https://doi.org/10.3390/jcm15156019
Submission received: 17 April 2026 / Revised: 26 June 2026 / Accepted: 2 July 2026 / Published: 3 August 2026
(This article belongs to the Special Issue Acute Hypoxemic Respiratory Failure: Progress, Challenges and Future)

Abstract

Efforts to liberate patients from invasive mechanical ventilation (MV) begin when the underlying cause of acute hypoxemic respiratory failure (AHRF) or adult respiratory distress syndrome (ARDS) that led to use of invasive ventilation has resolved or improved and patients can initiate spontaneous breaths. In preparation for liberation, clinicians transition patients to spontaneous modes of ventilation as soon as possible while ensuring that patients’ respiratory effort is not insufficient or excessive during weaning attempts. Concurrently, clinicians aim to minimize the effects of sedative and analgesic agents, screen daily to identify patients who are ready to undergo a spontaneous breathing trial (SBT), and conduct SBTs to help assess patients’ readiness for extubation. Extubation failure is rarely the consequence of a single physiological abnormality. Rather, it reflects the interaction of multiple mechanisms that often coexist, including an imbalance between respiratory system load and capacity, ineffective cough, and secretion burden among others. For these reasons, single weaning parameters and SBTs may fail to identify some patients who are at risk for extubation failure. Conversely, indices and scores that combine two or more parameters and newer techniques may provide mechanistic insights into the pathways that lead to extubation failure, help to characterize ‘at-risk’ phenotypes, and identify patients who may benefit from closer monitoring, targeted therapeutic strategies, and/or early application of noninvasive respiratory support strategies such as high-flow nasal cannula (HFNC) and bilevel noninvasive positive pressure ventilation (NIV).

1. Introduction

Liberation or weaning is the process during which the work of breathing is transferred from the ventilator back to the patient. Roughly 40% of the time spent on invasive mechanical ventilation is consumed by weaning [1]. Although invasive ventilation is effective, it is associated with the development of numerous complications, including respiratory muscle weakness, upper airway injury, ventilator-associated pneumonia (VAP) [2] and sinusitis [3]. The incidence of VAP increases exponentially after day 5 of invasive mechanical ventilation (MV) and has been associated with both increased morbidity and a trend toward increased mortality [4]. Accordingly, limiting the duration of invasive MV has been identified as a key research priority in critical care [5].
Timely and safe liberation (extubation) from invasive MV is a high-stakes decision. To reduce complication rates and improve outcomes, clinicians strive to shorten patients’ exposure to invasive MV. However, premature or failed attempts at extubation necessitating reintubation are associated with morbidity (e.g., VAP) and an approximate 8- to 10-fold increase in mortality [6]. While attempting to limit a patient’s exposure to invasive MV, clinicians ‘trade-off’ the risks associated with premature failed attempts at extubation (too early) and the complications associated with continued or protracted invasive MV (too late). To address liberation for patients with acute hypoxemic respiratory failure (AHRF) and acute respiratory distress syndrome (ARDS), five experts in weaning, extubation, and post-extubation respiratory support worked in parallel to review and summarize the literature in this narrative review across five domains (one domain per expert) pertaining to identifying liberation candidates, ventilator modes and reducing support, conduct of spontaneous breathing trials (SBTs), extubation, and the use of noninvasive post-extubation respiratory support strategies.

2. Identifying Candidates for Ventilator Liberation

2.1. Assessing Readiness for Weaning

A general medical assessment to identify candidates for ventilator liberation begins with the observation that the patient is recovering from the initial condition leading to the need for invasive MV [5]. The patient should be clinically stable with acceptable hemodynamic parameters receiving no more than minimal doses of vasoactive agents [7,8]. Classically, patients were not considered for liberation from MV if they were receiving vasoactive agents, but studies have demonstrated that low stable doses of vasopressors may be acceptable [8]. In a large, retrospective cohort study, ventilator liberation while receiving low doses of vasopressor agents (<0.1 ug/kg/min) was associated with lower mortality, decreased intensive care unit (ICU) length of stay (LOS), and no difference in extubation failure rates compared to the rest of the study group. By contrast, mortality and extubation failure rates were increased in patients disconnected from MV while receiving high doses of vasopressors [8].
Several physiologic parameters should be met prior to considering MV liberation, including the following items. An intact respiratory drive must be present. This can be determined by observing patient-triggered breaths on a ventilator supportive mode allowing spontaneous triggering or by briefly placing patients on a spontaneous mode and observing patient breath initiation. The patient should have acceptable gas exchange as indicated by an arterial partial pressure of oxygen (PaO2) > 60 mm Hg or arterial oxygen saturation (SaO2) > 90% on an FiO2 < 0.5 and positive end-expiratory pressure (PEEP) < 10 cm H2O, and a PaCO2 = ~40 mm Hg or consistent with a chronic, stable respiratory acidosis. [7,9]. A neurologic examination assessing cognition, muscle strength, and cranial nerve function should be performed [10], and the patient should be able to generate a cough [11].

2.2. Weaning Prediction

The likelihood of successful liberation from MV may be informed by the rapid shallow breathing index (RSBI). Yang and Tobin assessed several indexes first in a training cohort and then in a prospective validation cohort to determine the predictive accuracy of each for ventilator liberation outcomes [12]. The RSBI in this study was determined by discontinuing MV, allowing the patient to breathe room air for one minute, and then determining the ratio between the respiratory frequency and tidal volume. A threshold value < 105 breaths/min/L was determined to be more predictive of successful liberation outcomes than other measurements. Prospective clinical trials subsequently demonstrated the utility of SBTs in the assessment of candidates for MV liberation [13]. Vassilakopoulos and co-workers studied the determinants of liberation at the end of a T-piece trial and suggested that RSBI, when determined at the end of the SBT, was highly associated with successful discontinuation of MV [14]. Although the use of the RSBI at the end of an SBT to assess a patient for successful MV liberation was recommended by an early clinical practice guideline, experts noted that the positive likelihood ratio (1.49) for the association of the RSBI with successful liberation was modest in magnitude and suggested that other factors needed to be considered as part of a global assessment of liberation readiness [5]. Subsequently, a meta-analysis of 48 studies identified that although the sensitivity of the RSBI for predicting extubation success was high (83%), the specificity was modest (58%) and did not vary with use of different thresholds (<80 versus 80–150 versus <105 breaths/min/L), the support used during RSBI measurement, or the timing of RSBI measurement [15].

2.3. Daily Assessments

Once a patient has been identified as being a potential candidate for liberation from MV, daily assessments should be performed to determine readiness to liberate. Variation in practice is reduced and improved clinical outcomes are realized by the use of protocolized approaches to daily ventilator liberation assessment. Ely and colleagues randomized 300 patients to a daily two-step protocol of screening followed by an SBT compared to a usual care cohort where patients received screening alone. Patients in the protocolized arm had a median duration of MV of 4.5 days compared to 6 days in the usual care arm [16]. Kollef evaluated a similar protocol administered by nursing and respiratory therapy personnel and demonstrated improvements in the duration of MV [17].
More recent randomized controlled trials (RCTs) have evaluated different timing and frequency of screening, as well as different criteria to conduct SBTs. Hernández Martínez et al. found that the combination of earlier screening [initiated when the PaO2/(fractional concentration of oxygen) FiO2 > 180 mmHg] with more aggressive SBTs (conducted with PEEP 10 cmH2O) was associated with a higher reintubation rate [18]. Burns and coworkers evaluated both screening frequency (once versus more frequent) and SBT techniques [pressure support (PS) (>0 to 8 cm H2O) + PEEP (>0 to 5 cm H2O) versus T-piece] for patients who received invasive MV for more than 24 h. In the main analysis, neither screening frequency nor SBT technique influenced the time to successful extubation. Pairwise contrasts revealed two key findings: (i) when PS SBTs were used, more frequent screening (versus once-daily screening) increased the time to successful extubation, and (ii) when once-daily screening was used, PS + PEEP (versus T-piece) SBTs shortened the time to first successful SBT [19]. Findings from these trials caution against the combined use of early aggressive screening criteria and SBT settings and more frequent screening when PS SBTs are conducted.
Strategies to minimize the effects of sedative and narcotic agents on cognition and airway protective reflexes such as cough are important to consider in preparing the patient to be liberated from invasive ventilation [20,21,22]. Kress and colleagues prospectively studied 128 patients, randomizing them to either receive daily interruptions of sedative medications versus continuous infusion of sedatives. Daily interruptions of sedation reduced the duration of MV by more than 2 days and reduced ICU LOS by 3.5 days [23]. Clinical studies comparing cohorts of mechanically ventilated patients managed with protocols limiting sedatives compared to those receiving usual care consistently demonstrated that protocolized sedation management leads to shorter duration of ventilation [24,25].
The pairing of MV liberation assessments with daily sedation interruptions in protocols for MV liberation is an effective liberation strategy. Girard and co-workers randomized 336 critically ill mechanically ventilated patients to an intervention cohort pairing daily sedation interruption and SBT compared to a cohort that received daily SBT plus usual care for sedation management [26]. Patients receiving the paired management strategy had 3.1 fewer days of MV than the standard care arm. Clinical practice guidelines have provided recommendations to use protocols for MV liberation [5,20,27]. Cochrane reviews have supported the use of protocolized liberation strategies, indicating that protocols reduce the duration of MV, weaning duration, and ICU LOS [28].

3. Ventilator Modes and Reducing Ventilator Support

Liberating patients with AHRF or ARDS from invasive MV involves a stepwise process of transitioning the work of breathing from the ventilator to the patient. After intubation, during the ‘acute phase’, the ventilator fully supports patients’ workload of breathing and allows their respiratory muscles to rest. Key aims during this phase are to stabilize patients and ensure adequate gas exchange while preventing ventilator-associated lung injury through the use of lung-protective ventilation strategies, including judicious deep sedation and neuromuscular blockade. As their lungs improve, patients enter into the ‘recovery phase’, wherein their respiratory muscles begin to share in the work of breathing with the ventilator. This phase necessitates diaphragm-protective strategies to avoid overuse injury or underuse atrophy of the diaphragm. The final phase, or ‘weaning phase’, consists of SBTs and is typically followed by either extubation or tracheostomy insertion. Successful transition from ventilator dependence to independence hinges on identifying the right moment for patients to share in the work of breathing, choosing a mode of MV that optimizes patient–ventilator interaction, and adjusting ventilator support levels accordingly.
The first step in this transition involves moving from controlled to assisted ventilation. During the initial week of MV, assist-control is the most prevalent mode of MV used worldwide [29]. With fully controlled ventilation, ventilators trigger all breaths and patients’ diaphragms are passive and rapid deconditioning of the respiratory muscles may occur during this time, increasing the likelihood of prolonged weaning [9,30]. Reducing the set ventilator rate and allowing the patient to trigger ventilator breaths (i.e., assisted ventilation), or switching to a mode of MV wherein patients must trigger every ventilator breath (“partial” or “assist-only” mode) may reduce the risk for diaphragmatic atrophy. However, caution must be exercised, as early use of assisted ventilation for patients with ARDS may result in higher tidal volumes, transpulmonary pressures, and diaphragmatic excursion. In turn, this may increase the risk of developing self-inflicted lung injury and diaphragmatic myotrauma, especially when the respiratory drive and workload are excessive. For patients with AHRF and ARDS, finding the earliest and safest conditions to switch from controlled to assisted ventilation is imperative to protect the lungs and diaphragm.
The optimal time to transition to assisted ventilation has not been studied, and current ARDS guidelines do not specify the optimal conditions for transitioning to assisted ventilation. A target trial emulation using data from the WEAN SAFE (WorldwidE AssessmeNt of Separation of pAtients From ventilatory assistancE) study suggested that early switching (within 1 day of meeting eligibility defined by PaO2 to FiO2 ratio > 150 mmHg and not receiving neuromuscular blockade) compared to delayed switching was associated with shorter duration of MV without increased mortality [31]. Further evidence, corroborating that early identification and transition to assisted ventilation may be beneficial, comes from the PROMIZING (PROportional assist ventilation for miniMIZING the duration of MV) trial, which included criteria and screening tests for transitioning patients from assist-control to PS and to undergo a SBT [32]. Using this algorithm, 95 (25%) of patients were identified as being ‘ready to extubate’ despite the clinician’s predictions that they would require MV for more than 24 h [7].
Once patients are able to trigger all breaths, a supported mode of ventilation may be used. Options include assist-control, PS, or an adaptive ‘closed loop’ mode of ventilation such as proportional assist ventilation (PAV), neurally adjusted ventilatory assist (NAVA), adaptive support ventilation, or SmartCare™. (Table 1) The NAVIATOR (NAVa In Acute respiraTORy failure) study found that early implementation of NAVA (median 2 days post intubation) resulted in more ventilator-free days and fewer extubation failures compared to patients in the control arm who remained primarily on assist-control [33]. The PROMIZING Study compared proportional assist ventilation plus (PAV+) to PS and found that, while PAV+ did not significantly reduce MV duration when started later (median of 5 days post intubation), it was associated with faster weaning of sedative medications and fewer patient-days testing positive for delirium [34]. PS is the predominant mode used during the recovery phase [35]. Other modes (e.g., PAV and NAVA) are proprietary to specific ventilators.
Clinicians must also consider how to set the level of support for the chosen mode. Two studies provide evidence that gradual weaning of ventilator support may unnecessarily delay successful liberation [9,36]. These studies showed that protocolized SBTs, conducted daily or more frequently through an endotracheal tube or tracheostomy, resulted in shorter duration of MV and higher rates of weaning success compared to a strategy of gradually reducing the level of PS prior to unassisted breathing [9,36]. Although weaning ventilator settings does not seem to be helpful for intubated or tracheostomized patients, protocolized daily SBTs are helpful to identify patients who are ready for ventilator liberation.
Methods for monitoring respiratory mechanics during the transition phase have emerged over the last ten years. Various techniques can be used to assess respiratory drive (e.g., EAdi, P 0.1, mean inspiratory flow, respiratory muscle surface EMG) and respiratory muscle effort (e.g., ΔPes, ΔPocc, PMI, ΔPnose, USdi, ΔCVP, BREF models, and flow index) [37]. Additionally, the consequences of effort (e.g., tidal volume, electrical impedance tomography, dyspnea perception) can be evaluated. Respiratory drive is commonly monitored using the P0.1, a parameter that can be readily obtained from most contemporary ventilators. Clinicians target ventilator settings and adjust sedation to maintain P0.1 between 2 and 5 cm H2O. Conversely, ΔPocc and Pmus estimate respiratory effort. Clinicians aim for a ΔPocc that is not more negative than −15 or −20 cm H2O (predicts elevated diaphragmatic effort) and titrate ventilator support to maintain Pmus between 5 and 10 cm H2O. Additionally, clinicians can assess the mechanical consequences of respiratory drive and effort by monitoring tidal volume and maintaining the ΔPL,dyn ≤ 15 cm H2O [38].

4. Conduct of Spontaneous Breathing Trials

An SBT is a focused assessment of a patient’s ability to breathe without assistance or with low ventilator assistance on inspiration, expiration or both [39]. An SBT is a key component of a multifaceted and dynamic process to evaluate a patient’s ability to be liberated from ventilators. Whereas SBTs are conducted to assess patients’ readiness for ventilator liberation, extubation assessments assess patients’ ability to be liberated from the need for an airway. A large observational study of MV discontinuation practices identified that 18.2% of patients failed an initial SBT. Both initial failed (versus successful) SBTs and initial SBTs that occurred later (versus earlier) during the ICU course have been associated with worse clinical outcomes [35]. Whereas some patients will pass an initial SBT and be extubated, others may require more than one SBT before extubation, and some may not be extubated.
The optimal SBT technique for clinicians to use remains a matter of considerable debate with conflicting results in RCTs and meta-analyses. Among 1153 patients receiving MV, 30 min PS SBTs compared to 2 h T-piece SBTs resulted in significantly higher rates of successful extubation [40]. Conversely, in 969 patients at high risk for extubation failure, Thille and coworkers found that PS SBTs did not result in significantly more ventilator-free days at day 28, compared to T-piece SBTs [41]. A physiologic meta-analysis of one parallel group trial, eight randomized crossover and seven nonrandomized crossover studies found that T-piece SBTs may more closely replicate the work of breathing required after extubation [42]. Conversely, a pairwise meta-analysis of 40 RCTs (n = 6716) that compared alternative SBT techniques identified that, although patients were not more likely to pass PS (versus T-piece) SBTs [risk ratio (RR), 1.04 (95% CI; 0.97–1.11; p = 0.31 I2 = 73%], unless a single trial accounting for all heterogeneity was excluded [RR 1.09; 95% CI, 1.06–1.12; p < 0.001; I2 = 0%] (moderate quality evidence), they were significantly more likely to be successfully extubated with PS (versus T-piece) SBTs [RR 1.07 (95% CI; 1.04, 1.10; p < 0.001, I2 = 0%] (moderate quality evidence) (Figure 1) [43]. A subsequent network meta-analysis found that compared to T-piece SBTs, initial successful SBT rates were increased with PS [risk ratio (RR) 1.08, 95% confidence interval (CI) (1.05–1.11)], PS/automatic tube compensation (ATC) [1.12 (1.01–1.25)], high flow nasal cannulae (HFNC) [1.07 (1.00–1.13) (all moderate certainty), and ATC [RR 1.11, (1.03–1.20); low certainty] SBTs [44]. Compared to T-piece SBTs, successful extubation rates were increased with PS [RR 1.06, (1.03–1.09); high certainty], ATC [RR 1.13, (1.05–1.21); moderate certainty], and HFNC [RR 1.06, (1.02–1.11); high certainty] SBTs [44]. Although certainty was low, there did not appear to be a difference in reintubation rates with PS (versus. T-piece) SBTs; however, increased reintubation rates were identified with PS versus HFNC [RR 2.84, (1.61–5.03); moderate certainty] and ATC versus HFNC [RR 2.95 (1.57–5.56); moderate certainty] SBTs in a small number of trials [44].
Trials reporting SBTs have been hampered by design issues including inclusion of heterogeneous patients, mostly with high pre-test probability of success, variable use of protocolized screening and intervention application (applied to the initial SBT only or serially until a trial end-point is achieved), and heterogeneous outcomes reporting. Whereas SBT techniques that use pressure augmentation may lead to false positive results and contribute to a failed extubation, SBTs conducted without pressure augmentation may lead to false negative results and expose patients to continued invasive MV. Though no single SBT technique may be ideally suited for all diverse patients (e.g., neuromuscular weakness, pulmonary edema, chronic obstructive pulmonary disease) who require ventilator liberation, the use of inspiratory pressure augmentation during SBTs appears to increase the rate of successful extubation without increasing the rate of reintubation. Based on the best available evidence, a clinical practice recommended that patients have an initial SBT performed with inspiratory pressure augmentation [20].
Typically, SBTs are 30 to 120 min in duration. Only four RCTs have been conducted to compare SBTs of different durations either alone or in combination with other interventions. Of these, three RCTs compared SBTs of 30 to 120 min and one RCT compared 20 to 120 min [40,59,60,61]. Although 30 min SBTs may be reasonable for most patients, we do not know which patients may benefit from a longer SBT. No trial comparing alternative SBT durations was conducted to assess equivalency, and guidelines do not comment on SBT duration.
Conflicting data exist regarding ventilator reconnection after successful SBT completion. Coudroy et al. identified significant alveolar derecruitment at the end of an SBT, especially with T-piece (versus PS) SBTs, which was ameliorated by reconnecting patients to the ventilator for an hour [62]. One trial did not find a benefit to ventilator reconnection [63], while another trial [64] found a significant reduction in reintubation rate for patients who were invasively ventilated for more than 12 h.

5. Extubation

Several reviews have summarized predictors of weaning and extubation outcomes. In a 2018 systematic review, Baptistella and colleagues reviewed 43 articles (n = 7989) to identify 56 different parameters used to predict weaning and extubation outcomes. They identified that the RSBI was the most frequently investigated predictor (15 studies), followed by age and maximum inspiratory pressure (7 studies). The remaining 53 parameters were identified in fewer than 6 studies [65]. In 2021, Torrini and coworkers conducted a systematic review to explore factors associated with extubation failure in patients who passed a SBT and underwent planned extubation; they found 26 factors in 3 domains (comorbidities, acute disease severity, characteristics at the time of extubation) significantly associated with extubation failure and focused predominantly on respiratory and neurologic systems [66]. Using Bayesian multivariable meta-analysis, they identified 12 factors significantly associated with extubation failure (age, history of cardiac disease, history of respiratory disease, Simplified Acute Physiologic Score II score, pneumonia, duration of ventilation, heart rate, RSBI, negative inspiratory force, lower PaO2/FiO2 ratio, lower hemoglobin level and lower Glasgow Coma Scale (GCS) [67]), with GCS having the strongest association with extubation outcome [66]. In a systematic review of predictors of weaning failure, Sterr and colleagues identified 145 predictors in 140 studies (122 prospective, 18 retrospective) that could be categorized into 4 clusters: physiologic parameters (n = 61), scores and indices (n = 53), imaging procedures (n = 22), and machine learning models (n = 9) [68]. Finally, a systematic review of ten systematic reviews examining the diagnostic accuracy of 23 readiness tests conducted before, during or after SBTs identified lung ultrasound score, diaphragmatic RSBI, venous oxygen saturation, and brain natriuretic peptide as having high-to-moderate sensitivity and specificity for weaning failure [69].
Since numerous factors have been associated with weaning and extubation failure, attention has drawn away from single physiologic predictors to clinical scores and newer artificial intelligence systems that include multiple parameters [65,66]. Several indices, comprising two or more parameters, have been proposed, including the RSBI [7], CROP index [7], Core index [70], Timed Inspiratory Index (TIE) [71], respiratory rate variability [72] and diaphragmatic RSBI [73], to predict weaning and extubation outcomes. To aid prediction, parameters have also been combined into scores, including the Burns Weaning Assessment Program (BWAP) [74] and modified BWAP [75]; Weaning index [76]; original and new Integrative Weaning Index [77,78]; Integrative Pulmonary Index [79]; Extubation Prediction Score (ExPreS) score [80]; heart rate, acidosis, consciousness, oxygenation, and respiratory rate (HACOR) score [81]; and the COBRE-US model [82]. Newer approaches have utilized neural networks [83,84,85], convolutional neural networks [86], artificial intelligence [87], and machine learning [88,89,90,91] to predict weaning and extubation outcomes. Few indices or scores have been formally evaluated in RCTs. In 2006, Tanios et al. showed no difference in extubation failure rate and a longer duration of weaning for 153 patients who had the RSBI measured and used (at a threshold of 105 breaths/min/L) in the decision to wean compared to 151 patients who had the RSBI measured with no incorporation of the RSBI into the decision to wean [92]. In an RCT of 540 patients, Baptistella found that the use of the ExPreS score reduced the rate of reintubation within 48 h of extubation in per-protocol, but not in intention-to-treat, analyses. Rescue use of NIV and dependence on NIV after extubation for at least 48 h were considered to represent extubation failure in this trial [93]. Finally, specific airway predictors, largely reflecting airway patency and cough strength, have been investigated, including the GCS, cough strength [94], cuff-leak test [95], and peak cough flow [96].
Newer techniques such as lung–diaphragm–abdominal ultrasound and EIT provide insights into the mechanisms underlying extubation failure. Lung ultrasound permits bedside assessment of pulmonary edema, atelectasis, and consolidation [97]. Conversely, diaphragm ultrasound provides a window into the capacity of the primary inspiratory muscle to sustain spontaneous breathing [98]. A prospective observational study conducted in 50 mechanically ventilated, weaning-ready patients evaluated diaphragm excursion and diaphragmatic thickening fraction alongside conventional weaning parameters during SBTs [99]. Patients who failed SBTs had significantly lower diaphragm excursion and thickening fraction compared with those who succeeded. In a larger cohort study of 128 patients undergoing SBTs with planned extubation, diaphragmatic thickening fraction was significantly higher in the success group (mean of 42%) compared to the failure group (mean of 20%) [100]. These findings align with the conclusion of a systematic review that reported an association between diaphragm ultrasound parameters and weaning outcomes but highlighted substantial heterogeneity, variable thresholds, and dependence on measurement timing and ventilator settings [101]. EIT provides bedside assessment of regional ventilation distribution and changes in lung impedance during ventilator support transitions [102]. Wang and colleagues showed that higher pre-SBT global impedance and higher impedance in Region of Interest 2 during SBTs were associated with weaning success, whereas lower values were observed in patients who failed liberation from MV [103]. Phoophiboon et al. showed that a pronounced ventral-to-dorsal difference in ventilation distribution with EIT during SBTs may identify patients at risk of liberation failure [104]. Consequently, EIT may aid in elucidating underlying lung reserve and susceptibility to derecruitment during unassisted breathing and detect unfavorable ventilation patterns that emerge during the withdrawal of positive pressure.
More recently, abdominal muscle ultrasound has been used to evaluate expiratory muscle function and cough effectiveness in extubation assessments. Abdominal muscles play a key role in generating effective cough and clearing secretions, mechanisms that are critical for maintaining airway patency after extubation. Ultrasound assessment of abdominal muscle thickening has been shown to correlate with airway pressure generated during expiratory efforts and to be feasible and moderately reproducible in mechanically ventilated patients [105]. Importantly, among patients who passed an SBT, reduced abdominal muscle thickening during cough was associated with a high risk of liberation failure. These findings support the concept of a cough-ineffective phenotype, distinct from inspiratory muscle weakness or lung derecruitment, in which extubation failure arises from impaired secretion clearance rather than ventilatory insufficiency.
Extubation failure is rarely the consequence of a single physiological abnormality. Rather, it is typically multifactorial, reflecting the interaction of multiple mechanisms that may coexist, including an imbalance between respiratory system load and capacity, ineffective cough, secretion burden, and other factors. As a result, traditional weaning indices and SBTs that largely capture global respiratory patterns may fail to identify patients at risk for extubation failure. Techniques such as EIT and lung, diaphragm, and abdominal muscle ultrasound may provide mechanistic insights into the pathways leading to extubation failure and improve risk stratification. The potential role of these modalities is twofold. First, they may help identify patients at higher risk of extubation failure or enhance the prognostic performance of existing indices. These patients may benefit from closer post-extubation monitoring or early application of noninvasive respiratory support strategies. Second, they may help characterize the dominant phenotype underlying the risk for extubation failure and inform targeted preventive or therapeutic strategies. As such, these newer modalities offer complementary, mechanism-based insights into extubation failure. By identifying patients at increased risk for extubation failure and clarifying the physiological phenotype driving that risk, these newer modalities offer complementary, mechanism-based insights into extubation failure.

6. Post-Extubation Use of Noninvasive Respiratory Support Strategies

Noninvasive modalities of respiratory support, including HFNC and bilevel NIV, may mitigate the risk of extubation failure. A large systematic review and network meta-analysis of 36 RCTs and 6806 patients found that, compared with conventional oxygen therapy (COT), both HFNC and NIV probably reduce the rate of reintubation (moderate-certainty evidence) [106] (Table 2). The magnitude of benefit was greatest among patients with a higher baseline risk for reintubation. The number needed to treat (NNT) to prevent one reintubation was 60 among patients with a baseline reintubation risk of 5%, compared with an NNT of 11 among those with a baseline risk of 40%. Importantly, these benefits were observed only when noninvasive respiratory support strategies were applied prophylactically rather than as rescue therapy following clinical deterioration [106]. Despite reductions in reintubation rates, neither HFNC nor NIV were associated with a reduction in short-term mortality (moderate-certainty evidence) [106]. However, noninvasive respiratory support was associated with a lower incidence of ventilator-associated pneumonia (moderate-certainty evidence), likely mediated by reduced rates of reintubation.
In direct comparisons of HFNC and NIV, low-certainty evidence suggested no clear superiority of one modality over the other for preventing reintubation in the general critically ill population [106]. However, NIV may confer additional benefit in patients with obesity, particularly when used in combination with HFNC. This finding is supported by a meta-analysis of seven RCTs including 1933 patients with obesity, which demonstrated that NIV combined with HFNC probably reduces 7-day reintubation rates compared with COT or HFNC alone (moderate-certainty evidence) and was also associated with reduced 28-day mortality [107].
Guidelines from the European Society of Intensive Care Medicine (ESICM) and the European Respiratory Society (ERS) provide conditional or weak recommendations for the use of HFNC over COT in patients intubated for more than 24 h who have high-risk features, as well as in nonsurgical patients following extubation [108,109] (Figure 2). Guidelines also suggest the use of NIV for patients who would otherwise be extubated directly to NIV [108] and are considered to be at high-risk for extubation failure [109].
Several important uncertainties remain to guide the use of HFNC and NIV after extubation. Definitions for ‘high-risk’ patients vary substantially across studies. Specific populations, beyond those with obesity, that derive the greatest benefit from prophylactic NIV and HFNC remain to be characterized. The potential merits of newer interfaces and technologies, including helmet-based NIV or the newer asymmetric HFNC, have not been adequately evaluated in the post-extubation period. Well-designed trials are needed to define optimal patient selection, modality choice, and implementation strategies for noninvasive respiratory support devices.

Author Contributions

Conceptualization and oversight: K.E.A.B.; Investigation: All authors; Drafting: All authors; Review and approval of the final manuscript: All authors. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

No new data were created or analyzed in this study.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Esteban, A.; Alia, I.; Ibanez, J.; Benito, S.; Tobin, M.J.; The Spanish Lung Failure Collaborative Group. Modes of mechanical ventilation and weaning: A national survey of Spanish hospitals. Chest 1994, 106, 1188–1193. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  2. Pingleton, S.K. Complications of acute respiratory failure. Am. Rev. Respir. Dis. 1988, 137, 1463–1493. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  3. Niederman, M.S.; Ferranti, R.D.; Ziegler, A.; Merrill, W.; Reynolds, H.Y. Respiratory infection complicating long-term tracheostomy: The implication of persistent gram-negative tracheobronchial colonization. Chest 1984, 85, 39–44. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  4. Heyland, D.K.; Cook, D.J.; Griffith, L.; Keenan, S.P.; Brun-Buisson, C.; The Canadian Critical Care Trials Group. The attributable morbidity and mortality of ventilator associated pneumonia in the critically ill patient. Am. J. Respir. Crit. Care Med. 1999, 159, 1249–1256. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  5. MacIntyre, N.R.; Cook, D.J.; Ely, E.W., Jr.; Epstein, S.K.; Fink, J.B.; Heffner, J.E.; Hess, D.; Hubmayer, R.D.; Scheinhorn, D.J.; American College of Chest Physicians; et al. Evidence-based guidelines for weaning and discontinuing ventilatory support. Chest 2001, 120, 375S–395S. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  6. Kacmarek, R.M. Noninvasive Respiratory Support for Postextubation Respiratory Failure. Respir. Care 2019, 64, 658–678. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  7. Brault, C.; Mancebo, J.; Suarez Montero, J.-C. The PROMIZING trial enrollment algorithm for early identification of patients ready for unassisted breathing. Crit. Care 2022, 26, 188. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  8. Zarrabian, B.; Wunsch, H.; Stelfox, H.T.; Iwashyna, T.J.; Gershengorn, H.B. Liberation from invasive mechanical ventilation with continued receipt of vasopressor infusions. Am. J. Crit. Care Med. 2022, 205, 1053–1063. [Google Scholar] [CrossRef] [Scilit]
  9. Pham, T.; Heunks, L.; Bellani, G.; Madotto, F.; Aragao, I.; Beduneau, G.; Goligher, E.C.; Grasselli, G.; Laake, J.H.; Mancebo, J.; et al. Weaning from mechanical ventilation in intensive care units across 50 countries (WEAN SAFE): A multicentre, prospective, observational cohort study. Lancet Respir. Med. 2023, 11, 465–476. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  10. Sharshar, T.; Citerio, G.; Andrews, P.J.D.; Chieregato, A.; Latronico, N.; Menon, D.K.; Puybasset, L.; Sandroni, C.; Stevens, R.D. Neurological examination of critically ill patients: A pragmatic approach. Report of an ESICM panel. Intensive Care Med. 2014, 40, 484–495. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  11. Duan, J.; Zhang, X.; Song, J. Predictive power of extubation failure diagnosed by cough strength: A systematic review and meta-analysis. Crit. Care 2021, 25, 357. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  12. Yang, K.L.; Tobin, M.J. A prospective study of indexes predicting the outcome of trials of weaning from mechanical ventilation. N. Engl. J. Med. 1991, 324, 1445–1450. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  13. Esteban, A.; Frutos, F.; Tobin, M.J.; Alía, I.; Solsona, J.F.; Valverdu, V.; Fernández, R.; de la Cal, M.A.; Benito, S.; Tomás, R.; et al. A comparison of four methods of weaning patients from mechanical ventilation. N. Engl. J. Med. 1995, 332, 345–350. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  14. Vassilakopoulos, T.; Zakynthinos, S.; Roussos, C. The time-tension index and the frequency/tidal volume ratio are major pathophysiologic determinants of weaning failure and success. Am. J. Respir. Crit. Care Med. 1998, 158, 378–385. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  15. Trivedi, V.; Chaudhuri, D.; Jinah, R.; Piticaru, J.; Agarwal, A.; Liu, K.; McArthur, E.; Sklar, M.C.; Friedrich, J.O.; Rochwerg, B.; et al. The usefulness of the Rapid Shallow Breathing Index in predicting successful extubation: A systematic review and meta-analysis. Chest 2022, 161, 97–111. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  16. Ely, E.W.; Baker, A.M.; Dunagan, D.P.; Burke, H.L.; Smith, A.C.; Kelly, P.T.; Johnson, M.M.; Browder, R.W.; Bowton, D.L.; Haponik, E.F. Effect of the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N. Engl. J. Med. 1996, 335, 1864–1869. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  17. Kollef, M.H.; Shapiro, S.D.; Silver, P.; John, R.E.S.; Prentice, D.; Sauer, S.; Ahrens, T.S.; Shannon, W.; Baker-Clinkscale, D. A randomized, controlled trial of protocol-directed versus physician-directed weaning from mechanical ventilation. Crit. Care Med. 1997, 25, 567–574. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  18. Hernández Martínez, G.; Rodriguez, P.; Soto, J.; Caritg, O.; Castellví-Font, A.; Mariblanca, B.; García, A.M.; Colinas, L.; Añon, J.M.; Parrilla-Gomez, F.J.; et al. Effect of aggressive vs conservative screening and confirmatory test on time to extubation among patients at low or intermediate risk: A randomized clinical trial. Intensive Care Med. 2024, 50, 258–267. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  19. Burns, K.E.A.; Wong, J.; Rizvi, L.; Lafreniere-Roula, M.; Thorpe, K.; Devlin, J.W.; Cook, D.J.; Seely, A.; Dodek, P.M.; Tanios, M.; et al. Frequency of Screening and Spontaneous Breathing Trial Techniques: A Randomized Clinical Trial. JAMA 2024, 332, 1808–1821. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  20. Ouellette, D.R.; Patel, S.; Girard, T.; Morris, P.E.; Schmidt, G.A.; Truwit, J.D.; Alhazzani, W.; Burns, S.M.; Epstein, S.K.; Esteban, A.; et al. Liberation from mechanical ventilation in critically ill adults: An official American College of Chest Physicians/American Thoracic Society clinical practice guideline. Chest 2017, 151, 166–180. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  21. Devlin, J.W.; Skrobik, Y.; Gelinas, C.; Needham, D.M.; Slooter, A.J.C.; Pandharipande, P.P.; Watson, P.L.; Weinhouse, G.L.; Nunnally, M.E.; Rochwerg, B.; et al. Executive summary: Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit. Care Med. 2018, 46, 1532–1548. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  22. Boncyk, C.; Rolfsen, M.L.; Richards, D.; Stollings, J.L.; Mart, M.F.; Hughes, C.G.; Ely, E.W. Management of pain and sedation in the intensive care unit. BMJ 2024, 387, e079789. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  23. Kress, J.P.; Pohlman, A.S.; O’Connor, M.F.; Hall, J.B. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N. Engl. J. Med. 2000, 342, 1471–1477. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  24. Brook, A.; Ahrens, T.; Schaiff, R.; Prentice, D.; Sherman, G.; Shannon, W.; Kollef, M.H. Effect of a nursing-implemented protocol on the duration of mechanical ventilation. Crit. Care Med. 1999, 27, 2609–2615. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  25. Mansouri, P.; Javadpour, S.; Zand, F.; Ghodsbin, F.; Sabetian, G.; Masjedi, M.; Tabatabaee, H.R. Implementation of a protocol for integrated management of pain, agitation, and delirium can improve clinical outcomes in the intensive care unit: A randomized clinical trial. J. Crit. Care 2013, 28, 918–922. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  26. Girard, T.D.; Kress, J.P.; Fuchs, B.D.; Thomason, J.W.; Schweickert, W.D.; Pun, B.T.; Taichman, D.B.; Dunn, J.G.; Pohlman, A.S.; A Kinniry, P.; et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awake and Breathing Controlled trial): A randomized controlled trial. Lancet 2008, 371, 126–134. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  27. Girard, T.D.; Alhazzani, W.; Kress, J.P.; Morris, P.E.; Ouellette, D.R.; Alhazzani, W.; Burns, S.M.; Epstein, S.K.; Esteban, A.; Fan, E.; et al. An official American Thoracis Society/American College of Chest Physicians clinical practice guideline: Liberation from mechanical ventilation in critically ill adults. Am. J. Respir. Crit. Care Med. 2017, 195, 120–133. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  28. Blackwood, B.; Burns, K.E.; Cardwell, C.R.; O’HAlloran, P. Protocolized versus non-protocolized weaning for reducing the duration of mechanical ventilation in critically ill adult patients. Cochrane Database Syst. Rev. 2014, 11. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  29. Esteban, A.; Frutos-Vivar, F.; Muriel, A.; Ferguson, N.D.; Peñuelas, O.; Abraira, V.; Raymondos, K.; Rios, F.; Nin, N.; Apezteguía, C.; et al. Evolution of mortality over time in patients receiving mechanical ventilation. Am. J. Respir. Crit. Care Med. 2013, 188, 220–230. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  30. Goligher, E.C.; Dres, M.; Fan, E.; Rubenfeld, G.D.; Scales, D.C.; Herridge, M.S.; Vorona, S.; Sklar, M.C.; Rittayamai, N.; Lanys, A.; et al. Mechanical ventilation-induced diaphragm atrophy strongly impacts clinical outcomes. Am. J. Respir. Crit. Care Med. 2018, 197, 204–213. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  31. Reep, C.A.T.; Wils, E.J.; Fleuren, L.M.; Breskin, A.; Bellani, G.; Laffey, J.G.; Brochard, L.J.; Pham, T.; Heunks, L.; WEAN SAFE Investigators. Early versus Delayed Switching from Controlled to Assisted Ventilation: A Target Trial Emulation. Am. J. Respir. Crit. Care Med. 2025, 211, 975–983. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  32. Bosma, K.J.; Martin, C.M.; Burns, K.E.A.; Cortes, J.M.; Montero, J.C.S.; Skrobik, Y.; Thorpe, K.E.; Amaral, A.C.K.-B.; Arabi, Y.; Basmaji, J.; et al. Study protocol for a randomized controlled trial of Proportional Assist Ventilation for Minimizing the Duration of Mechanical Ventilation: The PROMIZING study. Trials 2023, 24, 232. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  33. Kacmarek, R.M.; Villar, J.; Parrilla, D.; Alba, F.; Solano, R.; Liu, S.; Montiel, R.; Rico-Feijoo, J.; Vidal, A.; Ferrando, C.; et al. Neurally adjusted ventilatory assist in acute respiratory failure: A randomized controlled trial. Intensive Care Med. 2020, 46, 2327–2337. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  34. Bosma, K.; Burns, K.E.A.; Martin, C.M.; Skrobik, Y.; Cortés, J.M.; Mulligan, S.; Lafreniere-Roula, M.; Thorpe, K.E.; Montero, J.C.S.; Chorro, I.M.; et al. Proportional-Assist Ventilation for Minimizing the Duration of Mechanical Ventilation. N. Engl. J. Med. 2025, 393, 1088–1103. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  35. Burns, K.E.A.; Rizvi, L.; Cook, D.J.; Lebovic, G.; Dodek, P.; Villar, J.; Slutsky, A.S.; Jones, A.; Kapadia, F.N.; Gattas, D.J.; et al. Ventilator Weaning and Discontinuation Practices for Critically Ill Patients. JAMA 2021, 325, 1173–1184. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  36. Jubran, A.; Grant, B.J.; Duffner, L.A.; Collins, E.G.; Lanuza, D.M.; Hoffman, L.A.; Tobin, M.J. Effect of pressure support vs unassisted breathing through a tracheostomy collar on weaning duration in patients requiring prolonged mechanical ventilation: A randomized trial. JAMA 2013, 309, 671–677. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  37. Tonelli, R.; Protti, A.; Spinelli, E.; Grieco, D.L.; Yoshida, T.; Jonkman, A.H.; Akoumianaki, E.; Telias, I.; Docci, M.; Rodrigues, A.; et al. Assessing inspiratory drive and effort in critically ill patients at the bedside. Crit. Care 2025, 29, 339. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  38. Bertoni, M.; Telias, I.; Urner, M.; Long, M.; Del Sorbo, L.; Fan, E.; Sinderby, C.; Beck, J.; Liu, L.; Qiu, H.; et al. A novel non-invasive method to detect excessively high respiratory effort and dynamic transpulmonary driving pressure during mechanical ventilation. Crit. Care 2019, 23, 346. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  39. Burns, K.E.A.; Rochwerg, B.; Seely, A. Ventilator Weaning and Extubation. Crit. Care Clin. 2024, 40, 391–408. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  40. Subirà, C.; Hernández, G.; Vázquez, A.; Rodríguez-García, R.; González-Castro, A.; García, C.; Rubio, O.; Ventura, L.; López, A.; de la Torre, M.C.; et al. Effect of Pressure Support vs. T-Piece Ventilation Strategies During Spontaneous Breathing Trials on Successful Extubation Among Patients Receiving Mechanical Ventilation: A Randomized Clinical Trial. JAMA 2019, 321, 2175–2182. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  41. Thille, A.W.; Gacouin, A.; Coudroy, R.; Ehrmann, S.; Quenot, J.-P.; Nay, M.A.; Guitton, C.; Contou, D.; Labro, G.; Reignier, J.; et al. Spontaneous-Breathing Trials with Pressure-Support Ventilation or a T-Piece. N. Engl. J. Med. 2022, 387, 1843–1854. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  42. Sklar, M.C.; Burns, K.; Rittayamai, N.; Lanys, A.; Rauseo, M.; Chen, L.; Dres, M.; Chen, G.-Q.; Goligher, E.C.; Adhikari, N.K.J.; et al. Effort to Breathe with Various Spontaneous Breathing Trial Techniques. A Physiologic Meta-analysis. Am. J. Respir. Crit. Care Med. 2017, 195, 1477–1485. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  43. Burns, K.E.A.; Khan, J.; Phoophiboon, V.; Trivedi, V.; Gomez-Builes, J.C.; Giammarioli, B.; Lewis, K.; Chaudhuri, D.; Desai, K.; Friedrich, J.O. Spontaneous Breathing Trial Techniques for Extubating Adults and Children Who Are Critically Ill: A Systematic Review and Meta-Analysis. JAMA Netw. Open 2024, 7, e2356794. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  44. Burns, K.E.A.; Sadeghirad, B.; Ghadimi, M.; Khan, J.; Phoophiboon, V.; Trivedi, V.; Builes, C.G.; Giammarioli, B.; Lewis, K.; Chaudhuri, D.; et al. Comparative effectiveness of alternative spontaneous breathing trial techniques: A systematic review and network meta-analysis of randomized trials. Crit. Care 2024, 28, 194. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  45. Esteban, A.; Alia, I.; Gordo, F.; Fernández, R.; Solsona, J.F.; Vallverdú, I.; Macías, S.; Allegue, J.M.; Blanco, J.; Carriedo, D.; et al. Extubation outcome after spontaneous breathing trials with T-tube or pressure support ventilation. Am. J. Respir. Crit. Care Med. 1997, 156, 459–465. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  46. Holanda, M.A.; Rocha, E.M.; Bandeira, R.M. Pressure support ventilation (PSV) versus T-tube as pre-extubation spontaneous breathing trials (SBT). Am. J. Respir. Crit. Care Med. 2000, 161, A559. [Google Scholar]
  47. Farias, J.A.; Retta, A.; Alia, I.; Olazarri, F.; Esteban, A.; Golubicki, A.; Allende, D.; Maliarchuk, O.; Peltzer, C.; Ratto, M.; et al. A comparison of twomethods to perform a breathing trial before extubation in pediatric intensive care patients. Intensive Care Med. 2001, 27, 1649–1654. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  48. Haberthur, C.; Mols, G.; Elsasser, S.; Bingisser, R.; Stocker, R.; Guttmann, J. Extubation after breathing trials with automatic tube compensation, T-tube, or pressure support ventilation. Acta Anaesthesiol. Scand. 2002, 46, 973–979. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  49. Koksal, G.M.; Sayilgan, C.; Sen, O.; Oz, H. The effects of different weaning modes on the endocrine stress response. Crit. Care 2004, 8, R31–R34. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  50. Colombo, T.; Boldrini, A.F.; Juliano, S.R.R.; Juliano, M.C.R.; Houly, J.G.S.; Gebara, O.C.E.; Cividanes, G.V.L.; Catão, E.C. Implementation, assessment and comparison of the T-tube and pressure-support weaning protocols applied to the intensive care unit patients who had received mechanical ventilation for more than 48 hours. Rev. Bras. Ter. Intensiva 2007, 19, 31–37. (In Portuguese) [Google Scholar]
  51. Zhang, B.; Qin, Y.Z. A clinical study of rapid-shallow-breathing index in spontaneous breathing trial with pressure support ventilation and T-piece. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2009, 21, 397–401. (In Chinese) [Google Scholar] [PubMed]
  52. Vats, N.; Singh, J.; Kaira, S. Extubation outcome after spontaneous breathing trials with T-tube or pressure support ventilation. Indian J. Physiother. Occup. Ther. 2012, 6, 86–89. [Google Scholar]
  53. Lourenco, I.S.; Franco, A.M.; Bassetto, S.; Rodrigues, A.J. Pressure support-ventilation versus spontaneous breathing with “T-tube” for interrupting the ventilation after cardiac operations. Braz. J. Cardiovasc. Surg. 2013, 28, 455–461. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  54. Zanfaly, H.E. Automatic tube compensation versus pressure support ventilation, continuous positive airway pressure and T-tube during spontaneous breathing trial. Alex. J. Anaesth. Intensive Care 2014, 17, 1–9. [Google Scholar]
  55. Teixeira, S.N.; Osaku, E.F.; Costa, C.R.L.M.; Toccolini, B.F.; Costa, N.L.; Cândia, M.F.; Leite, M.A.; Jorge, A.C.; Duarte, P.A.D. Comparison of proportional assist ventilation plus, T-tube ventilation, and pressure support ventilation as spontaneous breathing trials for extubation: A randomized study. Respir. Care 2015, 60, 1527–1535. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  56. Chittawatanarat, K.; Orrapin, S.; Jitkaroon, K.; Mueakwan, S.; Sroison, U. An open label randomized controlled trial to compare low level of pressure support and T-piece strategies for discontinuation of mechanical ventilation in a general surgical intensive care unit. Med. Arch. 2018, 72, 51–57. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  57. Santos Pellegrini, J.A.; Boniatti, M.M.; Boniatti, V.C.; Zigiotto, C.; Viana, M.V.; Nedel, W.L.; Marques, L.D.S.; Dos Santos, M.C.; De Almeida, C.B.; Pizzol, C.P.D.; et al. Pressure-support ventilation or T-piece spontaneous breathing trials for patients with chronic obstructive pulmonary disease—A randomized controlled trial. PLoS ONE 2018, 13, e0202404. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  58. Liu, F.; Shao, Q.; Jiang, R.; Zeng, Z.; Liu, Y.; Li, Y.; Liu, Q.; Ding, C.; Zhao, N.; Peng, Z.; et al. High-flow oxygen therapy to speed weaning from mechanical ventilation: A prospective randomized study. Am. J. Crit. Care 2019, 28, 370–376. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  59. Esteban, A.; Alia, I.; Tobin, M.J.; GIL, A.; Gordo, F.; Vallverdú, I.; Blanch, L.; Bonet, A.; Vázquez, A.; de Pablo, R.; et al. Effect of spontaneous breathing trial duration on outcome of attempts to discontinue mechanical ventilation. Spanish Lung Failure Collaborative Group. Am. J. Respir. Crit. Care Med. 1999, 159, 512–518. [Google Scholar] [CrossRef] [Scilit]
  60. Chawla, K.; Kupfer, Y.; Goldman, I. The spontaneous breathing trial: How long? Am. J. Respir. Crit. Care Med. 2001, 163, A892. [Google Scholar]
  61. Perren, A.; Domenighetti, G.; Mauri, S.; Genini, F.; Vizzardi, N. Protocol-directed weaning from mechanical ventilation: Clinical outcome in patients randomized for a 30-min or 120-min trial with pressure support ventilation. Intensive Care Med. 2002, 28, 1058–1063. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  62. Coudroy, E.; Lejars, A.; Rodriguez, M.; Frat, J.P.; Rault, C.; Arrive, F.; Le Pape, S.; Thille, A.W. Physiologic Effects of Reconnection to the Ventilator for 1 Hour Following a Successful Spontaneous Breathing Trial. Chest 2024, 165, 1406–1414. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  63. Dadam, M.M.; Goncalves, A.R.R.; Mortari, G.; Klamt, A.P.; Hippler, A.; Lago, J.U.; Ponikieski, C.; Catelano, B.A.; Delvan, D.; Westphal, G.A. The Effect of Reconnection to Mechanical Ventilation for 1 Hour After Spontaneous Breathing Trial on Reintubation Among Patients Ventilated for More Than 12 Hours: A Randomized Clinical Trial. Chest 2021, 160, 148–156. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  64. Fernandez, M.M.; González-Castro, A.; Magret, M.; Bouza, M.T.; Ibañez, M.; Carolina García, C.; Balerdi, B.; Mas, A.; Arauzo, V.; Añón, J.M.; et al. Reconnection to mechanical ventilation for 1 h after a successful spontaneous breathing trial reduces reintubation in critically ill patients: A multicenter randomized controlled trial. Intensive Care Med. 2017, 43, 1660–1667. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  65. Baptistella, A.R.; Sarmento, F.J.; da Silva, K.R.; Baptistella, S.F.; Taglietti, M.; Zuquello, R.A.; Nunes Filho, J.R. Predictive factors of weaning from mechanical ventilation and extubation outcome: A systematic review. Crit. Care 2018, 48, 56–62. [Google Scholar] [CrossRef] [Scilit]
  66. Torrini, F.; Gendreau, S.; Morel, J.; Carteaux, G.; Thille, A.W.; Antonelli, M.; Dessap, A.M. Prediction of extubation outcome in critically ill patients: A systematic review and meta-analysis. Crit. Care 2021, 25, 391. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  67. GCS Teasdale, G.; Jennett, B. Assessment of coma and impaired consciousness. A practical scale. Lancet 1974, 2, 81–84. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  68. Sterr, F.; Reintke, M.; Bauernfeind, L.; Senyol, V.; Rester, C.; Metzing, S.; Palm, R. Predictors of weaning failure in ventilated intensive care patients: A systematic evidence map. Crit. Care 2024, 28, 366. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  69. Grillo Ardila, C.F.; Triana-Moreno, L.C.; Laverde-Sabogal, C.E.; Mora-Arteaga, J.A.; Aguilar-Schotborgh, M.A.; Ramierez-Mosquera, J.J. Diagnostic accuracy of tests for assessing readiness for liberation from mechanical ventilation in adults: An overview of reviews. J. Intensive Care 2026, 14, 14. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  70. Delisle, S.; Francoeur, M.; Albert, M.; Ouellet, P.; Bellemare, P.; Arsenault, P. Preliminary evaluation of a new index to predict the outcome of a spontaneous breathing trial. Respir. Care. 2011, 56, 1500–1505. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  71. de Souza, L.C.; Guimarães, F.S.; Lugon, J.R. Evaluation of a new index of mechanical ventilation weaning: The timed inspiratory effort. J. Intensive Care Med. 2015, 30, 37–43. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  72. Seely, A.J.; Bravi, A.; Herry, C.; Green, G.; Longtin, A.; Ramsay, T.; Fergusson, D.; McIntyre, L.; Kubelik, D.; E Maziak, D.; et al. Do heart and respiratory rate variability improve prediction of extubation outcomes in critically ill patients? Crit. Care 2014, 18, R65. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  73. Spadaro, S.; Grasso, S.; Mauri, T.; Dalla Corte, F.; Alvisi, V.; Ragazzi, R.; Cricca, V.; Viondi, G.; Di Mussi, R.; Marangoni, E.; et al. Can diaphragmatic ultrasonography performed during the T-tube trial predict weaning failure? The role of diaphragmatic rapid shallow breathing index. Crit. Care 2016, 20, 305. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  74. Burns, S.M.; Ryan, B.; Burns, J.E. The weaning continuum use of Acute Physiology and Chronic Health Evaluation III, Burns Wean Assessment Program, Therapeutic Intervention Scoring System, and Wean Index scores to establish stages of weaning. Crit. Care Med. 2000, 28, 2259–2267. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  75. Jiang, J.R.; Yen, S.Y.; Chien, J.Y.; Liu, H.C.; Wu, Y.L.; Chen, C.H. Predicting weaning and extubation outcomes in long-term mechanically ventilated patients using the modified Burns Wean Assessment Program scores. Respirology 2014, 19, 576–582. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  76. Huaringa, A.J.; Wang, A.; Haro, M.H.; Leyva, F. The weaning index as predictor of weaning success. J. Intensive Care Med. 2013, 28, 369–374. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  77. Nemer, S.N.; Barbas, C.S.; Caldeira, J.B.; Cárias, T.C.; Santos, R.G.; Almeida, L.C.; Azeredo, L.M.; Noé, R.A.; Guimarães, B.S.; Souza, P.C. A new integrative weaning index of discontinuation from mechanical ventilation. Crit. Care 2009, 13, R152. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  78. Boniatti, V.M.; Boniatti, M.M.; Andrade, C.F.; Zigiotto, C.C.; Kaminski, P.; Gomes, S.P.; Lippert, R.; Miguel, D.C.; Felix, E.A. The modified integrative weaning index as a predictor of extubation failure. Respir. Care 2014, 59, 1042–1047. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  79. Kaur, R.; Vines, D.L.; Liu, L.; Balk, R.A. Role of integrated pulmonary index in identifying extubation failure. Respir. Care 2017, 62, 1550–1556. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  80. Baptistella, A.R.; Mantelli, L.M.; Matte, L.; Medru, C.; Fortunatti, J.A.; Costa, I.Z.; Haro, F.G.; de Turkot, V.L.O.; Baptistella, S.F.; de Carvalho, D.; et al. Prediction of extubation outcome in mechanically ventilated patients: Development and validation of the Extubation Predictive Score (ExPreS). PLoS ONE 2021, 16, e0248868. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  81. Chaudhuri, S.; Gupta, N.; Adhikari, S.D.; Todur, P.; Maddani, S.S.; Rao, S. Utility of the one-time HACOR score as a predictor of weaning failure from mechanical ventilation: A prospective observational study. Indian J. Crit. Care Med. 2022, 26, 900–905. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  82. Varón-Vega, F.; Giraldo-Cadavid, L.F.; Uribe, A.M.; Rincón, A.; Palacios, J.; Crevoisier, S.; Tuta-Quintero, E.; Ordoñez, L.; Boada, N.; Rincón, P.; et al. Utilization of spontaneous breathing trial, objective cough test, and diaphragmatic ultrasound results to predict extubation success: COBRE-US trial. Crit. Care 2023, 27, 414. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  83. Kuo, H.J.; Chiu, H.W.; Lee, C.N.; Chen, T.T.; Chang, C.C.; Bien, M.Y. Improvement in the Prediction of Ventilator Weaning Outcomes by an Artificial Neural Network in a Medical ICU. Respir. Care 2015, 60, 1560–1569. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  84. Hsieh, M.H.; Hsieh, M.J.; Chen, C.M.; Hsieh, C.C.; Chao, C.M.; Lai, C.C. An Artificial Neural Network Model for Predicting Successful Extubation in Intensive Care Units. J. Clin. Med. 2018, 7, 240. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  85. Gottschalk, A.; Hyzer, M.C.; Geer, R.T. A comparison of human and machine-based predictions of successful weaning from mechanical ventilation. Med. Decis. Mak. 2000, 20, 160–169. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  86. Jia, Y.; Kaul, C.; Lawton, T.; Murray-Smith, R.; Habli, I. Prediction of weaning from mechanical ventilation using Convolutional Neural Networks. Artif. Intell. Med. 2021, 117, 102087. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  87. Yang, H.C.; Hao, A.T.; Liu, S.C.; Chang, Y.C.; Tsai, Y.T.; Weng, S.J.; Chan, M.C.; Wang, C.Y.; Xu, Y.Y. Prediction of Spontaneous Breathing Trial Outcome in Critically Ill-Ventilated Patients Using Deep Learning: Development and Verification Study. JMIR Med. Inform. 2025, 13, e64592. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  88. Fenske, S.W.; Peltekian, A.; Kang, M.; Markov, N.S.; Zhu, M.; Grudzinski, K.; Bak, M.J.; Pawlowski, A.; Gupta, V.; Mao, Y.; et al. Developing and validating machine learning models to predict next-day extubation. Sci. Rep. 2025, 15, 27552. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  89. Zhao, Q.Y.; Wang, H.; Luo, J.C.; Luo, M.H.; Liu, L.P.; Yu, S.J.; Liu, K.; Zhang, Y.J.; Sun, P.; Tu, G.W.; et al. Development and Validation of a Machine-Learning Model for Prediction of Extubation Failure in Intensive Care Units. Front. Med. 2021, 8, 676343. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  90. Park, J.E.; Kim, D.Y.; Park, J.W.; Jung, Y.J.; Lee, K.S.; Park, J.H.; Sheen, S.S.; Park, K.J.; Sunwoo, M.H.; Chung, W.Y. Development of a Machine Learning Model for Predicting Weaning Outcomes Based Solely on Continuous Ventilator Parameters during Spontaneous Breathing Trials. Bioengineering 2023, 10, 1163. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  91. Burns, K.E.A.; Allan, J.; Herry, C.; Lee, E.; Santos-Taylor, M.; Scales, N.; Kay, P.; Gouskos, A.; Greco, P.; Every, H.; et al. Liberation from mechanical ventilation using Extubation Advisor Decision Support (LEADS): Protocol for a Multicentre Pilot Trial. BMJ Open 2025, 15, e093853. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  92. Tanios, M.A.; Nevins, M.L.; Hendra, K.P.; Cardinal, P.; Allan, J.E.; Naumova, E.N.; Epstein, S.K. A randomized, controlled trial of the role of weaning predictors in clinical decision making. Crit. Care Med. 2006, 34, 2530–2535. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  93. Oliveira, J.A.; Klein, F.; Guzatti, N.G.; Kojoroski, A.P.F.; de Vargas Ciello, H.; da Silva, D.J.; Locatelli, J.; da Silva, L.F.; Parise, M.; Spörr, A.V.; et al. Effect of the extubation predictive score (ExPreS) on reintubation in the ICU: A randomized controlled trial. Crit. Care 2026, 30, 343. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  94. Varón-Vega, F.; Rincón, A.; Giraldo-Cadavid, L.F.; Tuta-Quintero, E.; Palacios, J.; Crevoisier, S.; Duarte, D.C.; Poveda, M.; Cucunubo, L.; Monedero, P. Assessing the reproducibility and predictive value of objective cough measurement for successful withdrawal of invasive ventilatory support in adult patients. BMC Pulm. Med. 2024, 24, 218. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  95. Kriner, E.J.; Shafazand, S.; Colice, G.L. The endotracheal tube cuff-leak test as a predictor for postextubation stridor. Respir. Care 2005, 50, 1632–1638. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  96. Salam, A.; Tilluckdharry, L.; Amoateng-Adjepong, Y.; Manthous, C.A. Neurologic status, cough, secretions and extubation outcomes. Intensive Care Med. 2004, 30, 1334–1339. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  97. Koenig, S.; Mayo, P.; Volpicelli, G.; Millington, S.J. Lung Ultrasound Scanning for Respiratory Failure in Acutely Ill Patients: A Review. Chest 2020, 158, 2511–2516. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  98. Hermans, G.; Demoule, A.; Heunks, L. How I perform diaphragmatic ultrasound in the intensive care unit. Intensive Care Med. 2024, 50, 2175–2178. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  99. Kaur, A.; Sharma, S.; Singh, V.P.; Krishna, M.R.; Gautam, P.L.; Singh, G. Sonographic assessment of diaphragmatic thickening and excursion as predictors of weaning success in the intensive care unit: A prospective observational study. Indian J. Anaesth. 2022, 66, 776–782. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  100. Rabuske, W.C.; Westphal, G.; Rático, G.; do Nascimento, S.A.; Baptistella, A.R. Diaphragmatic ultrasound for extubation readiness: The role of thickening fraction. J. Crit. Care 2026, 91, 155253. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  101. Parada- Gereda, H.M.; Tibaduiza, A.L.; Rico-Mendoza, A.; Molano-Franco, D.; Nieto, V.H.; Arias-Ortiz, W.A.; Perez-Terán, P.; Masclans, J.R. Effectiveness of diaphragmatic ultrasound as a predictor of successful weaning from mechanical ventilation: A systematic review and meta-analysis. Crit. Care 2023, 27, 174. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  102. Franchineau, G.; Jonkman, A.H.; Piquilloud, L.; Yoshida, T.; Costa, E.; Rozé, H.; Camporota, L.; Piraino, T.; Spinelli, E.; Combes, A.; et al. Electrical Impedance Tomography to Monitor Hypoxemic Respiratory Failure. Am. J. Respir. Crit. Care Med. 2024, 209, 670–682. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  103. Wang, G.; Zhang, L.; Li, B.; Niu, B.; Jiang, J.; Li, D.; Yue, Z.; Weng, Y. The Application of Electrical Impedance Tomography During the Ventilator Weaning Process. Int. J. Gen. Med. 2021, 14, 6875–6883. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  104. Phoophiboon, V.; Antenor Rodrigues, A.; Fernando Vieira, F.; Ko, M.; Madotta, F.; Schreiber, A.; Sun, N.; Sousa, M.L.A.; Docci, M.; Brault, C.; et al. Ventilation distribution during spontaneous breathing trials predicts liberation from mechanical ventilation: The VISION study. Crit. Care 2025, 29, 11. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  105. Schreiber, A.F.; Bertoni, M.; Coiffard, B.; Fard, S.; Wong, J.; Reid, W.D.; Brochard, L.J.; Piva, S.; Goligher, E.C. Abdominal Muscle Use During Spontaneous Breathing and Cough in Patients Who Are Mechanically Ventilated: A Bi-center Ultrasound Study. Chest 2021, 160, 1316–1325. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  106. Fernando, S.M.; Tran, A.; Sadeghirad, B.; Burns, K.E.A.; Fan, E.; Brodie, D.; Munshi, L.; Goligher, E.C.; Cook, D.J.; Fowler, R.A.; et al. Noninvasive respiratory support following extubation in critically ill adults: A systematic review and network meta-analysis. Intensive Care Med. 2021, 48, 137–147. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  107. Pensier, J.; Naudet-Lasserre, A.; Monet, C.; Capdevila, M.; Aarab, Y.; Lakbar, I.; Chanques, G.; Molinari, N.; De Jong, A.; Jaber, S. Noninvasive respiratory support following extubation in critically ill adults with obesity: A systematic review and network meta-analysis. eClinicalMedicine 2025, 79, 103002. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  108. Rochwerg, B.; Einav, S.; Chaudhuri, D.; Mancebo, J.; Mauri, T.; Helviz, Y.; Goligher, E.C.; Jaber, S.; Ricard, J.-D.; Rittayamai, N.; et al. The role for high flow nasal cannula as a respiratory support strategy in adults: A clinical practice guideline. Intensive Care Med. 2020, 46, 2226–2237. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  109. Oczkowski, S.; Ergan, B.; Bos, L.; Chatwin, M.; Ferrer, M.; Gregoretti, C.; Heunks, L.; Frat, J.-P.; Longhini, F.; Nava, S.; et al. ERS clinical practice guidelines: High-flow nasal cannula in acute respiratory failure. Eur. Respir. J. 2022, 59, 2101574. [Google Scholar] [PubMed]
Figure 1. Association of pressure support compared with T-piece spontaneous breathing trials on successful extubation. CI = confidence interval [40,41,45,46,47,48,49,50,51,52,53,54,55,56,57,58]. Reprinted from Ref. [43].
Figure 1. Association of pressure support compared with T-piece spontaneous breathing trials on successful extubation. CI = confidence interval [40,41,45,46,47,48,49,50,51,52,53,54,55,56,57,58]. Reprinted from Ref. [43].
Jcm 15 06019 g001
Figure 2. Use of high flow nasal cannulae (HFNC) in the clinical setting. Rochwerg B, et al [108]. Intensive Care Medicine, 2020, Springer Nature. Reproduced with permission from Springer Nature.
Figure 2. Use of high flow nasal cannulae (HFNC) in the clinical setting. Rochwerg B, et al [108]. Intensive Care Medicine, 2020, Springer Nature. Reproduced with permission from Springer Nature.
Jcm 15 06019 g002
Table 1. Closed-loop modes of ventilation used during liberation from ventilation.
Table 1. Closed-loop modes of ventilation used during liberation from ventilation.
Newer ModesMain Feature
Proportional Assist VentilationAirway pressure is amplified according to respiratory mechanics and the set level of assistance to be proportional to the instantaneous effort of the patient.
Neurally Adjusted Ventilatory AssistMeasures the electrical activity of the diaphragm (EAdi) and provides positive pressure synchronously and in proportion to the amplitude of the EAdi signal.
Adaptive Support VentilationTargets a desired minute ventilation by providing the optimal combination of tidal volume and respiratory rate according to Otis’ equation (calculates an ideal respiratory rate that is associated with the least energy expenditure by considering minute ventilation, dead space and the expiratory time constant of the respiratory system). Algorithm calculates the expiratory time constant and adjusts the I:E ratio and inspiratory pressure to reduce work of breathing.
SmartCareAlgorithm adjusts the level of pressure support provided according to 8 respiratory diagnoses that aim to achieve a respiratory comfort zone based on respiratory rate, tidal volume and end-tidal carbon dioxide. It automatically conducts spontaneous breathing trials once predetermined settings are achieved.
Table 2. Network and absolute estimates evaluating the efficacy of the interventions for prevention of reintubation in critically ill adults.
Table 2. Network and absolute estimates evaluating the efficacy of the interventions for prevention of reintubation in critically ill adults.
ComparisonNetwork Odds Ratio (95% CI)Absolute Risk Difference (95% CI)Number Needed to TreatGRADE
NIPPV vs. conventional oxygen0.65 (0.52–0.82)–5.18 (–8.09 to –2.26)20 (13 to 45)Moderate a
HFNC vs. conventional oxygen0.63 (0.45–0.87)–3.84 (–6.7 to –0.98)26 (15 to 102)Moderate a
NIPPV vs. HFNC1.04 (0.78–1.38)–1.34 (–4.4 to 1.72)N/ALow a,b
HFNC + NIPPV vs. conventional oxygen0.38 (0.19–0.74)–10.25 (–18.49 to –2.01)10 (6 to 50)Moderate a
HFNC + NIPPV vs. NIPPV0.58 (0.3–1.11)–5.07 (–13.38 to 3.24)N/ALow a,b
HFNC + NIPPV vs. HFNC0.6 (0.33–1.08)–6.41 (–14.13 to 1.31)N/ALow a,b
Abbreviations: NIPPV: noninvasive positive pressure ventilation, HFN: high-flow nasal cannula, GRADE: grading of recommendations assessment, development, and evaluation, OR: odds ratio, CI: confidence interval. a Lowered for risk of bias. b Lowered one level for imprecision as CIs don’t exclude harms. Reprinted from Ref. [107].
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Burns, K.E.A.; Bosma, K.J.; Ferreyro, B.L.; Chaudhuri, D.; Seely, A.J.E.; Ouellette, D.R. Liberation from Mechanical Ventilation in Acute Hypoxemic Respiratory Failure or Adult Respiratory Distress Syndrome: A Review. J. Clin. Med. 2026, 15, 6019. https://doi.org/10.3390/jcm15156019

AMA Style

Burns KEA, Bosma KJ, Ferreyro BL, Chaudhuri D, Seely AJE, Ouellette DR. Liberation from Mechanical Ventilation in Acute Hypoxemic Respiratory Failure or Adult Respiratory Distress Syndrome: A Review. Journal of Clinical Medicine. 2026; 15(15):6019. https://doi.org/10.3390/jcm15156019

Chicago/Turabian Style

Burns, Karen E. A., Karen J. Bosma, Bruno L. Ferreyro, Dipayan Chaudhuri, Andrew J. E. Seely, and Daniel R. Ouellette. 2026. "Liberation from Mechanical Ventilation in Acute Hypoxemic Respiratory Failure or Adult Respiratory Distress Syndrome: A Review" Journal of Clinical Medicine 15, no. 15: 6019. https://doi.org/10.3390/jcm15156019

APA Style

Burns, K. E. A., Bosma, K. J., Ferreyro, B. L., Chaudhuri, D., Seely, A. J. E., & Ouellette, D. R. (2026). Liberation from Mechanical Ventilation in Acute Hypoxemic Respiratory Failure or Adult Respiratory Distress Syndrome: A Review. Journal of Clinical Medicine, 15(15), 6019. https://doi.org/10.3390/jcm15156019

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop